Overcoming Skepticism When Commercializing Novel Therapies

Interview with Taopatch USA CEO Dmitri Leonov

Listen to the Episode

0:000:00

Listen to the Episode

0:000:00

About the Guest

Dmitri Leonov is the co-founder and CEO of Taopatch USA and an advisor in a number of transformative technology projects. After seven fruitful years at Overture and later at Yahoo, Dmitri dove into the startup world. After founding several companies, including Sanebox.com, he was intrigued by frequency medicine and started his current venture by bringing Taopatch to the United States from Italy, where it was first invented.

Interview Summary

Dmitri Leonov was on a different path before he found his way to healthtech. Upon graduating, he spent several years in investment banking and then a few more at Overture (later acquired by Yahoo). Bitten by the startup bug, he then launched Sanebox.com because he was excited to find solutions to address the growing problem of email overload to help with mental health and productivity. 

Dmitri had always been interested in the wellness industry. He says, โ€œI wanted to work on something more meaningful, especially coming from Yahoo, where we had so many really smart people focused on optimizing clicks, essentially.โ€

Inspired by Einstein's prophetic quote, "The future of medicine will be the medicine of frequencies," Dmitri started thinking about frequency medicine. 

โ€œIf you look at the world from the quantum mechanics point of view, everything is a wave and a particle. It's a wave before it gets observed, and then it becomes a particle,โ€ explains Dmitri. This fundamentally means we can influence things through resonance. While this might sound outlandish to someone from a traditional medicine background, Dmitri sees potential.

Driven by this fascination with the upside of frequencies, Dmitri co-founded Taopatch USA, a company offering frequency healing solutions for a wide range of imbalances. Taopatch โ€“ essentially a patch with conductor wires on it โ€“ is a patented, FDA-cleared, Class 1 medical device that merges ancient acupuncture concepts with the latest in nanotechnology and light therapy, aiming to provide a natural, non-chemical way for the body to reset and find balance.

Taopatch is like a tiny, wearable prism and mirror with embedded nanomaterials. When itโ€™s placed on the skin, the patch captures the bodyโ€™s heat, or infrared energy, and converts it into a broader spectrum of light. This light is then reflected back into the wearerโ€™s body, targeting specific acupuncture points. โ€œIt's a combination of light therapy and acupuncture,โ€ Dmitri explains.

Light therapy has a solid scientific foundation, with over 9,000 studies exploring its benefits for injury recovery, neurological disorders, mood enhancement, and more. Taopatch utilizes light to help the body "remember" how to communicate efficiently with itself, leading to improvements in balance, posture, sleep, focus, athletic performance, and pain relief.

The technology was first developed by Fabio Fontana, an Italian biomedical engineer who faced a debilitating injury. Desperate for relief from chronic pain, Fabio developed a form of light therapy that proved to be the only solution that offered lasting benefits for his health issues. His breakthrough was the discovery of a unique nanomaterial โ€“ quantum dots โ€“ which powers Taopatch and has been reported to help with conditions like Multiple Sclerosis, Parkinson's Disease, pain, and fatigue.

The success of Taopatch made headlines last summer when Novak Djokovic credited it as "the biggest secret of his career." The company is now working with about 20 Olympians who will compete in the upcoming summer games.

Key Learnings From Dmitriโ€™s Experience

  • Taopatch has scored some impressive publicity from world-renowned tennis player Novak Djokovic and famous actor Robert Downey Jr. But you canโ€™t fake your way into that kind of spotlight. You have to have a working device and the capabilities to scale. Build steady momentum, and be prepared to seize those moments of luck when they come your way.

  • When it comes to market development, first identify those who are receptive to what you're doing. Examine your potential partnersโ€™ business models and look for alignment. Once you have a solid base of customers, optimize for organic growth using customer testimonials and word-of-mouth. 

  • Running huge clinical trials requires serious capital and resources. If youโ€™ve already proven the safety of your device, you can use a creative strategy, like a money-back guarantee, to reach a greater audience and let their testimonials demonstrate the validity of your product.

Build a Great Product and Luck Will Find You

Despite the fact that frequency medicine tends to raise some eyebrows, Taopatch is steadily gaining commercial traction.

Last summer, Novak Djokovic, the tennis superstar, publicly credited a small wearable device as "the biggest secret of his career." This wasn't a paid sponsorship โ€“ Taopatch had organically found its way to Djokovic through his trainer. From there, things took off. The company is now on its way to becoming a staple among athletes, currently working with over 20 Olympians.

Then Robert Downey Jr. โ€“ Iron Man himself โ€“ was spotted wearing Taopatch at the Golden Globes while accepting a prestigious award. This is definitely a signal for Taopatchโ€™s appeal to a broader audience.

So, how can you replicate this kind of exposure for your solution? Dmitri emphasizes there's no shortcut. You have to have a product that actually delivers. Then, you want to be prepared to scale with a solid business model.

Beyond that, it takes relentless effort and the ability to seize opportunities when they come. Taopatch's success stems from years of dedication, strategic connections โ€“ like the regional link to Djokovic's trainer, and staying vigilant for those moments of luck. As Dmitri puts it, "Momentum builds, and then you start to see these nice synchronicities happen. That's when luck comes your way." 

How to Find Your Early Adopters

Dmitri recognizes that educating the broader market about Taopatch's technology is crucial. He mostly credits Fabio Fontana, the inventor of Taopatch, for spearheading this effort.

Fabioโ€™s strategy was to focus on the most receptive audience: open-minded practitioners. โ€œFinding those right partners who would be a good fit, just looking at their business model, that's step one,โ€ Dmitri explains. In other words, you need to identify those who are receptive to what you're doing. 

In Taopatch's case, acupuncturists are a natural fit. The device complements their work by allowing patients to continue a subtle yet consistent form of therapy after they leave the office. It bridges the gap between those intense acupuncture sessions with a lower-intensity frequency treatment.

For the past decade, Fabio has targeted chiropractors, physical therapists, acupuncturists, and naturopaths โ€“ those who are intrinsically inclined toward holistic approaches.

Of course, โ€œluckโ€ plays a role too. Many of Taopatch's practitioner partnerships have blossomed organically. Satisfied customers experiencing positive results often shared their stories with their doctors. This word-of-mouth momentum is crucial in educating the market.

Bulletproof Clinical Trials: Customer Testimonials

Dmitri says, โ€œYou could run a really high-powered, pretty solid clinical study that's well-designed. But you're still going to have people poke holes in it.โ€ But that shouldnโ€™t stop you from moving forward with your efforts. Even if youโ€™re not working on an atypical product, there will be critics.

Sometimes, demonstrable results with a smaller group of people can have a massive impact. Taopatch's early work with a Multiple Sclerosis patient is a prime example โ€“ immediate benefits prompted larger, year-long studies that confirmed and reinforced the initial findings.

Plus, funding is always a challenge for fledgling medtech or heatlhtech ventures. If you can't afford to fund clinical studies, focus on the dramatic improvements you can document on a case-by-case basis. For instance, Dmitri reports that Taopatch has plenty of placebo-controlled studies under their belt, along with striking "before and after" videos of patients regaining function.

"It doesn't matter what the studies say, the only study that matters is a sample of one โ€“ and that's you." Whether your product works is ultimately up to the individual. With this lens, Taopatch offered a money-back guarantee, which led to thousands of people purchasing and trying the patch on their own. Hence, the multitude of customer testimonials the company has.

Dmitri says, "Even if a device has been studied across 30,000 people, it still might not work for that one person." But if your product is safe and there's a way for people to try it risk-free, even if the study group isn't huge, those individual success stories can break through the skepticism.  

Check Out the Podcast โ†’

Sponsors

  • FastWave Medical: Named MD+DI's Company of the Year, FastWave is one of the hottest medtech startups in the cardiovascular space. See how you can invest here.

  • Fundraising Cohort: Planning to raise capital for your startup? This live, 4-week workshop, led by Scott Nelson, is designed to help founders and CEOs tell a sharper story, get investor meetings that matter, and close real capital. Join the waitlist here.

Donโ€™t Forget

Interested in advertising with us?
Get in Touch โ†’

Want to learn from more startup CEOs?
Check Out the Archive โ†’

Forwarded this email?
Join for Free โ†’

Who's Scott Nelson again?
See His Bio โ†’

Transcript

0:00:01 But what I always say is it actually doesn't matter what the studies say. The only study that matters has a sample of one, and that's not-- that, that's you.

0:00:12 The only person it matters whether it works or not for is you, and the only way to know is to try it. And so the way we'd-- we've addressed it is by having a money-back guarantee. Uh, we know that it's completely safe.

0:00:27 Welcome to MedSider, where you can learn from the brightest founders and CEOs in medical devices and health technology.

0:00:34 Join tens of thousands of ambitious doers as we unpack the insights, tactics, and secrets behind the most successful life science startups in the world. Now, here's your host, Scott Nelson. Hey, everyone. It's Scott.

0:00:48 In this episode of MedSider, I sat down with Dmitry Leonov, co-founder and CEO of TauPatch USA. After several fruitful years at Overture and later Yahoo, Dmitry dove into the startup world.

0:00:58 After founding several companies, including SaneBox.com, he was intrigued by frequency medicine and started his current venture by bringing TauPatch to the United States from Italy, where it was first invented.

0:01:07 Here are a few of the key things that we discussed in this conversation. First, TauPatch has recently scored some impressive publicity from world-renowned tennis player Novak Djokovic and famous actor Robert Downey Jr.

0:01:18 But you can't fake your way into that kind of spotlight. You have to have a working device and the capabilities to scale. Build steady momentum and be prepared to seize those moments of luck when they come your way.

0:01:27 Second, when it comes to market development, first identify those who are going to be receptive to what you're doing. Examine your potential partners' business models and look for alignment.

0:01:36 Once you have a solid base of customers, optimize for organic growth using customer testimonials and word of mouth. Third, running huge clinical trials requires serious capital and resources.

0:01:45 If you've already proven the safety of your device, you can use a creative strategy, like a money-back guarantee, for example, to reach a greater audience and let their testimonials demonstrate the validity of your product.

0:01:55 All right. Before we jump into this episode, I wanted to let you know that the latest edition of MedSider Mentors is now live.

0:02:01 We just published Volume 5, which summarizes the key learnings from the most popular MedSider interviews over the last several months with incredible entrepreneurs like Gabriel Jones, CEO of Proprio, Kirsten Carroll, CEO of CanDo Health, Dr.

0:02:13 David Alpert, founder of AliveCor, Greg Bullington, CEO of Magnolia Medical, and other leaders of some of the hottest startups in our space.

0:02:20 Look, it's tough to listen or read every interview that comes out, even the best ones, but there are so many valuable lessons you can pick up from the founders and CEOs that join our program.

0:02:28 So that's why we decided to create MedSider Mentors. It's the easiest way for you to learn from the world's best medical device and health technology entrepreneurs in one central place.

0:02:37 To check out the latest volume, head over to medsiderradio.com/mentors. Premium members get free access to all past and future volumes. If you're not a premium member yet, you should definitely consider signing up.

0:02:49 In addition to every volume of MedSider Mentors, you'll get full access to the entire library of interviews dating back to 2010.

0:02:57 You'll also be able to see all of our playbooks, which are handpicked collections of the most insightful interviews with the brightest founders and CEOs that join our program.

0:03:05 Whether you're looking to master capital fundraising, navigate early-stage development, tackle regulatory challenges, understand reimbursement, or position your venture for a meaningful exit, MedSider playbooks have you covered.

0:03:16 And last, considering that fundraising can be one of the most daunting tasks for any startup, we created a meticulous database of investors right at your fingertips.

0:03:24 Explore a wealth of VC funds, private equity firms, angel groups, and more, all eager to invest in medical device and health technology startups. Access to this database is a premium member exclusive, so don't miss out.

0:03:37 Learn more about MedSider Mentors and our premium memberships by visiting medsiderradio.com/mentors. All right. Without further ado, let's jump into the interview. [upbeat music] All right, Dmitry.

0:03:54 Welcome to MedSider. Appreciate you coming on, man. Thank you for having me. Yeah, this should be a fun conversation. Um, I love interviewing kind of more health tech entrepreneurs, right?

0:04:03 Uh, this show probably is, it's, it's 75% kind of, uh, focused on more traditional medical device, but I love, uh, I love bringing over a lot of insights, right, to what you're doing in kind of the health tech space and, and, and trying to blend the worlds together a little bit.

0:04:16 But, um, let's start, um, at the top, right, with kinda your, your sort of professional bio leading up to, uh, kinda co-founding, uh, TauPatch USA. Yeah. So my background is tr- very non-medical.

0:04:29 So I, I started in investment banking after, um, after the university, then, um, spent a few years working at, uh, Yahoo, or actually a company that was acquired by Yahoo, and then kind of the, joined the combination of, of those two.

0:04:46 Uh, and this is back when Yahoo was actually cool. [laughs] Um, um, and people still remember it. Um, and then- Was that, was that when, was that when Marissa Mayer was there then? Before. Or was that prior?

0:04:56 I mean, uh- Oh, before... my, my journey there ended when, right around when she joined. Um- Okay... but, uh, yeah, it was, it was actually a really, really cool place to work for, for a long time.

0:05:07 The-- if you look at the, the alumni from Yahoo from those days, nowadays, I mean, extremely successful people, so really, really, really good team. Great network. Anyway, so then I, I got the startup bug and, um,

0:05:21 launched my first startup, then the second one. And, uh, a few years ago, I kind of, I really got focused on health tech and, um, you know, wellness in general,

0:05:35 um, just from personal experience and just wanting to work on something, let's say, more meaningful [laughs] right? And realizing that especially coming from, uh, from Yahoo days,

0:05:49 where we had so many really smart people focused on optimizing clicks, essentially, right? So optimizing monetization for, for clicks, and it just seems like, or seemed like not the most

0:06:02 Not the best use of time of, um, all, [laughs] all of these really smart people. And it's good to see.

0:06:08 I, I, I'm seeing a lot of my, uh, former colleagues from, uh, internet and media and g- especially gaming move into this, you know, wellness tech world.

0:06:18 And it's really good to see, 'cause again, they're really, really smart people. And, uh, to... It's a good idea to leverage [laughs] all of our combined focus on, on stuff that really matters for humanity. Mm-hmm.

0:06:30 To- 100% agree. In fact, um, I was having this conversation, uh, just recently at a, um, at a cardiovascular conference, right?

0:06:36 We were a ha- ha- having dinner with a, um, an interventional cardiologist in Boston who's, you know, pretty, pretty well-respected, or I should say very well-respected in his own right.

0:06:45 And we were talking about, like, the, um, kind of this, this trend within more kind of traditional business and tech circles, right?

0:06:51 We're talking specifically about the All-In podcast and, you know, how a lot of those guys are, are talking about, you know, newer health things.

0:06:57 Um, even, even, even kind of on, on the verge of, like, sort of medical, medical treatments, and it's just, it's good. I mean, the, the, the awareness and kind of overall interest it seems is, is, is burgeoning, right?

0:07:05 And to your point, those are some of the smartest people, right, in, in, in the world working on, on tech companies, right?

0:07:11 It'd be, it'd be great to have some of those, uh, g- get some of that, uh, uh, that juice, right, into, into areas that- Yeah... that impact, impact health and, uh, health and wellness. So, um- And funding.

0:07:21 Funding very important there as well, right? Not just time and focus, but money. Oh, 100%.

0:07:26 100%, 'cause that's the, the reality is, like, most of these devices take quite a bit of funding, right, to ever see the light of day. Mm-hmm. So yeah, no, no doubt. Um, so the company that you're...

0:07:35 One of the companies or maybe the main company you're working on, right, I referenced this is, is at the, at the outset of this interview is Tau Patch, right? Yeah.

0:07:41 And obviously fo- you know, focused as the, as the co-founder of Tau Patch USA. It's spelled, just for everyone listening, Tau Patch. It's T-A-O P-A-T-C-H, Tau Patch. Uh, and the website is taupatch.co.

0:07:52 We'll link to it in the full, the full write-up on MedCiter, um, like we always do.

0:07:55 But Dmitry, give us a sense for kind of, like, what at a, at a high level, without g- going too far into the weeds right now, give us a sense for kind of what, what this is and kind of how you, how you came about the, the technology.

0:08:06 Sure. So what it is is a really, really fascinating piece of technology. It's, um, nano material, so it's a nanotechnology device that essentially when you place it on your skin, it can capture your body heat,

0:08:21 in other words, your infrared energy, and it can convert it to a broader spectrum of light, all the way from infrared to ultraviolet.

0:08:31 So you can kind of think of it like a prism where, you know, one kind of light enters it and then it splits, splits it into a broader spectrum.

0:08:39 But then it also, it's like a mirror because it reflects this light back into your body and back into your nervous system. And the way we describe Tau Patch is, uh, it's a combination of light therapy and acupuncture.

0:08:52 Hm. Um, so light therapy is actually a really well-researched form of medicine.

0:08:58 There are over 9,000 studies, uh, peer-reviewed, you know, double-blind studies on PubMed s- studying different kinds of light therapy and the effect of light on different system of, systems of our body.

0:09:11 And there's a lots, lots of research on, you know, injury recovery, on neurological disorders, on, you know, mood and, you know, s- the seasonal disorder.

0:09:23 That, that's what, that's what comes to mind [laughs] first when we think about light therapy.

0:09:27 But the, the kind of light therapy that Tau Patch is closest to is, is called low level laser therapy, and what it is, is basically you're taking a very weak, uh, laser, so it's not something that, that's gonna cut through steel, but it just shines light on your, [laughs]

0:09:45 on your body. And, uh, placing it on points where you have pain or injury has tremendous results. Okay. And, uh, so Tau Patch was actually invented by a brilliant, uh, bioengineer from Italy named Fabio Fontana.

0:10:02 Um, over, well over a decade ago, he started, uh, working on this, and the, you know, the story is that he himself had a, a really devastating injury and he was just in a, in a lot of pain and had to take, you know, painkillers, like mountain of painkillers every day just to survive, and nothing would help him

0:10:20 other than painkillers just for a few hours.

0:10:22 And so the, the, the one thing that he got tremendous benefit from was light therapy, uh, this low, low level laser therapy where you, you know, shine a light on some part of your body and your pain goes away.

0:10:34 And so the aha moment was, um, how do we take that technology and make it more available, make it more consistent?

0:10:44 And so Tau Patch, the, the main discovery is this nano material, uh, and the nano material is called, uh, quantum dots.

0:10:53 Interestingly enough, last, just last year, the gentleman who invented quantum dots back in the '90s won the Nobel Prize for Physics. So it's, it's a really unique, uh, piece of, uh, technology. It's, it's really...

0:11:08 It's, it's a nano material, so there's no elect- there's no battery, there's no power.

0:11:13 All it's doing is, again, it's converting one form of light into another, and because of this, it works for two and a half years without, without battery.

0:11:23 And so whereas, you know, normally with light therapy, you would go to,

0:11:27 um, a, you know, physician's office and apply it for, you know, a few minutes or maybe even an hour if you're lucky, and then, and then you kind of go back to your normal life, and yes, there are some lingering effects, but it really doesn't allow your body to kind of to integrate all, all this therapy.

0:11:45 And so by placing Tau Patch on your body, and you can put it, you can just apply it with a, a skin tape or Band-Aid.

0:11:53 By placing it on specific points where, where you have injury, where you have pain, and also we have different protocols based on, uh, acupuncture, Chinese medicine-

0:12:03 And so placing the patches on those points has a really dramatic effect, and we, we, we can talk about it more, but, uh, it's, it almost seems too good to be true in, in many cases.

0:12:14 But again, we have couple dozen studies at this point. Many are, uh, double blind, placebo controlled, and so we see just amazing results from, from putting this little... Doesn't even look like a device.

0:12:29 It looks like a little plastic coin. [laughs] Yeah. But, but it, it can do miracles. Oh, yeah, yeah. Um, the...

0:12:37 So, so, so just at, at a, at a high level, if I'm understanding this correctly, wearable, wearable patch, and I presume, let's, let's take an example. Like, let's say I, I injured my shoulder, right?

0:12:45 Am I wear- am I adding multiple TAO patches, right? Or is it literally just one? Is it sort of, uh, treatment area dependent on, in terms of, like, the number of, of, uh, patches that you'd place in that area?

0:12:55 Honestly, just one is, is fine. If it's a, if it's just one injury, you can place one patch on the point where it hurts, and it will, it will make the pain go away.

0:13:03 And we can talk more about actually what happens in, in your body. Um, but then we, we have other protocols for, you know, for example, for

0:13:13 neurological disorders like multiple sclerosis or Parkinson's, which is actually has been the, the majority of, of our customers over the, over the years. Uh, for them, it's a m- minimum of two patches that are required.

0:13:27 Um, some protocols require three or four. Uh, but normally two or three is, is more than enough, at least to get started. Got it. Got it.

0:13:36 And the, the nano material that you're using basically captures or utilizes the, the heat, the infrared heat coming from bodies, right?

0:13:43 And sort of repurposes, right, into, into low-level light therapy or LLT, uh- Exactly... as you mentioned. Yep. Got it. Got it. Cool. Uh, I think that helps. And again, ta- taopatch.co is the website.

0:13:54 Uh, if you're listening and don't get to the full write-up, it's T-A-O Patch, uh,.co, uh, just as it sounds. Um, for those listening, I'm sure you might be naturally skeptical, right?

0:14:03 Uh, the, this idea of shining lights at your body and then, you know, uh, we... Then re- receiving, you know, some sort of, uh, some sort of host of benefits, right, from this.

0:14:12 But it's, a- as, as Dmitry mentioned, it's, it's, it's, it's a very, very proven sort of modality and technology. In fact, there's, you know, there's, um,

0:14:21 uh, physicians, PhDs, et cetera, you know, that speak on podium, uh, on, on this, on this, on this data, this, you know, light therapy, photobiomodulation, et cetera.

0:14:30 Um, in fact, uh, Dmitry, I'm not sure if you're aware, like, before Fastๆณข, which is the company I, I s- I, I started, I, I spend, I spend my time on now, I co-founded a company called Joovv, which is in the, in the light therapy space.

0:14:39 And I was very, very skeptical back in 2015. Mm-hmm. When I first came upon th- this therapy, I was like, "What?

0:14:44 You shine, you know, bright ri- bright red or, you know, uh, uh, invisible near-infrared lights on your body, and, and supposedly there's all, all, all these, all these benefits."

0:14:52 But, uh, sure enough, there's tons of data, uh, that, that support it, um, for such a wide variety of conditions. It's quite, quite, quite amazing. Uh, and it's legit. You know, it's le- it's legit science.

0:15:02 So, um, so yeah, uh, this is, this should be, uh...

0:15:05 I'm looking forward to kind of learning a little bit more about your experience, um, you know, commercializing the technology and kind of where, where you're headed next.

0:15:11 So, uh, with that said, uh, give us a sense, kind of a high-level sense of kind of what, where you're, where you're at. I mean, if I go to the website, it looks like you're actively commercializing.

0:15:19 Give us a better sense of kind of where the company's at, um, now and maybe where you're headed over the next 12 months. Yeah. Um, so we, we have, um, new products coming up. That's, that's the big, [laughs]

0:15:29 I guess one, one of the big things we're doing. Well, so we've been very... For the last few, few years, we've been really focused on neurological disorders simply because, um,

0:15:41 this is where we've seen, uh, we've been able to make the biggest impact. Um, basically what, when the light from...

0:15:47 And, you know, you know all about this, but, but when the light from, um, you know, TAO Patch or any light therapy enters your nervous system, it kind of tunes our nerve...

0:15:57 It reminds our nervous system what proper communication between neurons is supposed to be like, and it kind of speeds up this communication between neurons, uh, which has all sorts of, all sorts of effects.

0:16:08 But the, the first system that gets affected is your proprioception, meaning your motion, your balance, movement, location in space, essentially. And there are two kinds of people for whom

0:16:23 this improvement is, is particularly useful.

0:16:25 So the first kind is athletes, because for them, you know, shaving off a few, you know, even a split second, right, from a, [laughs] from a 100-meter race can be a, can be a huge difference.

0:16:35 Uh, and then the second group is people whose nervous system is not functioning properly. And so th- these are people with multiple sclerosis, Parkinson's, uh, fibromyalgia, chronic pain of, um, different kinds.

0:16:51 And so for them, it's, it's been a really, really important, uh, important improvement to their life. Last summer, we, we got a,

0:17:01 um, [laughs] a really nice piece of publicity from, uh, Novak Djokovic, who, who wears TAO Patch, and he, at the press conference, when somebody asked him, "What, you know, what is this thing you're wearing?"

0:17:11 He said, um, [laughs] well, first he, he made a joke about wanting to be Iron Man because you wear it kind of on your chest, so it remind, it reminds of Iron Man.

0:17:20 But then he said it's the biggest secret of his career, uh, and he wouldn't be sitting here without it today. Um, so, and so that, that, that really helped us a lot. So we're moving into...

0:17:32 We have moved into sports space, and we have a lot of, uh, sports teams that are, um, that are using us. We, we have, uh, about 20 Olympians in these upcoming Olympic Games, um, many of whom are our spokespeople.

0:17:46 And, um, w- we're, what we're focused on now is moving into kind of more of the, uh, everyone else bucket. [laughs] So it's not people with neurological disorders, not people, not a- professional athletes. Um, you know,

0:18:02 I guess, uh, uh, the one, one category I would describe is somebody like myself, an aging amateur athlete [laughs]... who, where stuff starts to hurt a little bit.

0:18:13 So, so, um, uh, just, you know, improving overall wellbeing and longevity and, you know, some kind of-... chronic, you know, or pain here and there on your back, um, those things are incredibly helpful.

0:18:26 And then, uh, another u- really interesting thing that happened, uh, couple weeks ago, weeks ago, so the actor playing Iron Man, Robert Downey Jr.- Mm-hmm...

0:18:35 was at the Golden Globes and he won the, the award for Best Actor for Oppenheimer. And as he is, um, holding up the award, you can see Tau Patch on his wrist. So and so he's wearing it on the,

0:18:50 the emotional wellbeing points. Mm-hmm. So we have actually a lot of customers who don't have any physical issues and don't have any pain, but they're wearing it for feeling better emotionally.

0:19:00 And this is, this is a really, really big thing that we're, that we're focusing on. Uh, that, that's cool. I lo- I love those stories, and I wanna get into those in a little bit more detail.

0:19:08 Um, and if I understand you right, like the next sort of direction for the company in terms of targeting would be people that listen to the Huberman podcast, right? [laughs] It sounds like, right?

0:19:16 People that are- Yeah... proactive about their health, you know, kind of on, on the leading edge of that, but don't necessarily have maybe a, a, a certain condition, so to speak, that they're trying to treat.

0:19:24 But, um, that's a, that's a, that's a really helpful overview.

0:19:26 And I, I do wanna ask you a little bit more about like your experiences not only kind of, you know, sort of engaging with, you know, big names like Novak, uh, or, or others for that matter.

0:19:36 But before, uh, before we get there, um, just to level set the audience too, when, when Dmitry mentioned like light therapy, you're sort of, um, tuning the nervous system.

0:19:44 This is not distinctly different than the neuromodulation devices that we see often in med tech, right? Where it's like an implantable device. Mm-hmm.

0:19:51 You're in essence, you're, you're modulating the body's nervous system. In the Tau Patch, you're just sort of doing that naturally, right?

0:19:57 'Cause you're using the, your body's own heat to repurpose that energy to enhance cell signaling. And that's...

0:20:04 I, I remember having a conversation, gosh, this has, this has been a while ago, but we were looking at, um, the efficacy of using green tea, uh, in combination with light therapy. Mm-hmm.

0:20:13 And I always thought, oh, it must be because of the aura, the high auric score of green tea, right? That probably is, is maybe synergistic with light therapy.

0:20:20 And, and no, when you look at the data, it's actually because green tea helps induce better cell signaling, which is naturally synergistic to light therapy. I mean, they work kind of in parallel, right?

0:20:29 I mean, the, the goal is, again, you're, you're, you're modulating your, your nervous system to, to function better.

0:20:33 So I just wanted to call it out 'cause it, uh, it resonates with me and I just wanted to help, uh, make sure, make ensure people are kind of tracking with kind of the underlying mechanism here that, that we're, that we're talking about.

0:20:42 Well, actually, can I, can I just... So you said, you used the word resonate, and that's- Yeah... that's a really important point. Yeah.

0:20:47 Um, so in this whole field of, um, frequency medicine, right, which is v- very, very young and very early on...

0:20:55 And by the way, um, there's a quote by Albert Einstein who said that future medicine will be the medicine of frequencies. Mm. At least the quote is attributed to him.

0:21:04 I, I haven't, like, heard him say it on t- on, you know, video anywhere, but [laughs] it's, um, it, it's... Look it up. It's, uh, [laughs] it's used a lot. Yeah.

0:21:15 But anyway, uh, so frequency medicine is a really fascinating form of medicine. So we have, um, light, sound, electromagnetic frequencies, right?

0:21:23 And the reason why this is, uh, so revolutionary and why, you know, I, I personally agree with, [laughs] with Mr. Einstein, this is a, you know...

0:21:35 But if you look at the, at the world from the quantum mechanics point of view, um, everything is a wave and a particle. And, and, you know, it's a wave before it gets observed, and then it becomes a particle, right?

0:21:48 So just very 100-year-old quantum physics. Mm.

0:21:52 And if everything is actually a wave, then the, one of the most, the, the, one of the most kind of basic or fundamental ways of affecting something is through other waves, is, and specifically through resonance, because, you know, everything does resonate with, with everything else.

0:22:09 And so, yes, to a traditional mainstream community, to a doctor who was, who went to a normal med school, this is kind of crazy talk. Mm-hmm. And, and frankly, even just seeing how or, or reading a study on how

0:22:24 shining a very faint light on your, on an acupoint, right, how that can have any kind of an effect, it sounds crazy, so ergo it must be placebo in effect. Mm-hmm.

0:22:37 And again, we have plenty of placebo control studies, and other people do as well. And if you look at...

0:22:42 If you go on our website, taupatch.co, you can see the videos of people before and after, and, and most of them are taken on the same day.

0:22:49 So these are people who couldn't walk in a straight line before because of the disorder they have. They put the patches on and they start walking normally.

0:22:57 And we, we, we just finished a 800-person study on pain, and the results are, uh, just incredible. I mean, we're, we're seeing... Again, same thing.

0:23:09 Within minutes the pain goes away, and it's place- again, placebo controlled study. Yeah. Uh, no, that, that, that, that, that's awesome.

0:23:16 And I love the fact that you're actually, like, allocating resources towards, towards actually proving this out in studies, right?

0:23:22 'Cause that, that overcomes a lot of the natural skepticism that comes with newer therapies like this.

0:23:26 But, um, um, I, the, when, when I kind of on, on this topic of, like, you know, you talked about the Albert Einstein quote as an example, right? Um, the analogy I...

0:23:35 'Cause we have a fair amount of, like, investors and, and entrepreneurs that listen to the program, and there's this notion in tech that's like, if you...

0:23:42 from an investment perspective of, like, you wanna be investing in, um, in things that, like, all the nerds are doing on the weekend, right, in their spare time, right? Mm-hmm.

0:23:50 That's usually like a, a, a sign of like- Mm... this really smart group of people, they're like passionate about, whether it's Bitcoin 10 years ago, AI five to seven years ago, et cetera.

0:24:00 Like they're doing, they're spending like their weekend time doing, you know, messing around with this stuff. Mm-hmm. That's where the trends are.

0:24:05 And I, I think the same thing holds true for a lot of, like, whether you call it health and wellness or, or medicine, is like things that are happening at Remedy Studio in LA as an example, and, and in a sound, sound bath.

0:24:17 There, there's people paying out of, out of pocket a lot of money for these services- They're, they're working in some capacity, right?

0:24:24 Otherwise, they wouldn't keep paying out-of-pocket cash for, like, these services, these products, et cetera.

0:24:29 So it's like that's, that's sort of the framework I like to use when it comes to a lot of this, a lot of this stuff is, like, it's, it's, it's early. It feels maybe kind of crazy.

0:24:36 Uh, but if people are, are, are doing it and paying a lot of money for it, they're not gonna just paying cash for something that's not working. So clearly it's making a difference. You know what I mean?

0:24:46 And so that's li- we're gonna likely see some of this stuff come to fruition, you know, in, in the more mainstream, you know, call it five to, five to 10 years ago, so... [upbeat music] Hey, everyone.

0:24:54 Let's take a quick break to talk about FastWave Medical, the company I co-founded and lead as CEO. Our team is developing next-generation intravascular lithotripsy systems for complex calcific disease.

0:25:04 This type of therapy is often referred to as IVL. The market size for IVL is over $9 billion, and there's only one player in the space with a market cap of around 10 billion.

0:25:13 So naturally, there's a lot of investor interest in FastWave. In fact, we opened up an opportunity to invest directly into the company almost a year ago, and we were blown away by the interest from our community.

0:25:23 So much so that we ended up closing $8 million from our supporters in less than a month. Typically, opportunities to invest in venture-backed startups like FastWave are pretty rare.

0:25:31 So based on significant and continued demand, we highly encourage you to sign up for our wait list to avoid missing out on the next opportunity to invest. You can opt in at fastwavemedical.com/invest.

0:25:42 And if this is the first time you're hearing about FastWave, here are some key highlights. As I mentioned before, we are sitting on an IVL market valued at over $9 billion with only one incumbent.

0:25:51 Second, we just completed our first-in-human study with eight treated patients, resulting in 100% lesions crossed and a 93% reduction in mean diameter stenosis from baseline.

0:26:01 We've raised over $20 million to date from corporate venture and cardiovascular KOLs, and we have five granted patents by the USPTO and multiple FTOs.

0:26:09 If you're interested in empowering physicians with advanced IVL technology while potentially benefiting from a fast-growing IVL market, head over to fastwavemedical.com/invest and check out the details.

0:26:20 Again, that's fastwavemedical.com/invest. All right, let's get back to the rest of the conversation. [upbeat music] I want to cover clinical, clinical work, right?

0:26:31 'Cause that's, I think that- that's uni- that's unique and a lot of, like, more traditional health, health tech companies, uh, don't, don't do that sort of work.

0:26:38 But let's start with, with Novak, and you kind of even referenced, you know, s- even some of the Olympians that are, that are gonna be using Tal- Talpatch, uh, in the, in the, in the, um, uh, the coming summer games here.

0:26:46 But I think for a lot of people listening, a lot of entrepreneurs especially, are like, "I've got this cool thing that I'm working on. I'd love to get it in the hands of so and so," right?

0:26:55 Or, "Oh, yeah, I'd love for my device to be, you know, talked about at the Golden Globes or something, or worn at the Golden Globes."

0:27:01 So when you think about kind of what you've learned engaging with some of these more high-profile people, right? Uh, I mean, are, are there a couple tips that you can share?

0:27:08 I mean, has this been, like, a proactive effort, or is it, like, largely inbound? What does that look like for, for you as you've, as you, as you, in your experience at Talpatch? It's a, it's a mix.

0:27:18 And, um, I guess the, [laughs] the one thing I'd say, there's no shortcut. [laughs] It's grinding and, and, uh, and making it happen. But, um, with Novak, we, we have a partner who,

0:27:31 uh, you know, is from the same, same area, so he, he got into h- into the hands of his, uh, his trainer, and so we've been working with him. We have been working with him for a couple of years now.

0:27:41 Um, in the case of Robert Downey Jr., we found out from one of our customers who was watching the Golden Globes. [laughs] Because the...

0:27:49 So it was purchased by his assistant, which we, so we didn't really, you know, connect, connect the dots. [laughs] But it's, uh, yeah, it's, it's...

0:27:57 I think it's, it's probably a combination of both because we, we have been,

0:28:03 you know, pushing it and, and talking to lots of people over the years and just eventually, um, I think the, the, the momentum kind of picks up, and then you start to see these, these, the nice synchronicities and, uh, and, and luck, right?

0:28:17 Luck comes in. [laughs] Yep. Uh. Yeah, the, the more momentum, right, the more action, typically, you know, quote unquote, "luck, luck follows," uh, for sure. Exactly.

0:28:26 I, I love your point, though, about, like, there, there are no shortcuts to this stuff because I think a lot of people would look at be like, uh, would look at, like, a story like the No- Novak.

0:28:33 You know, he, he mentioned the thing, right? In a, in a big kind of, uh, you know, with a lot of attention, et cetera. Robert Downey Jr., et cetera.

0:28:40 But to your, to your point about there's really no shortcuts, you have to have, one, a product that actually works, right?

0:28:46 Um, and you know, clearly you can manufacture it at scale, which is no easy, easy feat, right, either. And so, um, a lot of, a lot of this, I mean, there's, there's...

0:28:55 I would imagine there's a lot of, lot, lot of grind and persistence to kind of create this, this, you know, luck, so to speak, right? [laughs] Yeah. Yeah, exactly. Yeah. Yeah.

0:29:04 Um, and then, um, I guess the, the next I, uh, next question I, I kind of had for you, and it, and it's, it's sort of similar, right? Because you guys have been quite successful.

0:29:12 I think, uh, based on our research, it looks like you've, you know, you distributed over 300,000 devices, right?

0:29:18 Um, you know, over 2,000 healthcare providers are, you know, are offering this to their, you know, their, their clients and their patients.

0:29:26 And so those numbers are impressive alone, especially against the backdrop of something that, to your point earlier, this isn't, you know, docs don't typically learn about this in, in, in medical school, right?

0:29:37 Um, e- even in more of a sort of a naturopathic sort of school, they're probably not gonna understand this. Um, yet you've been able to kind of overcome a lot of that skepticism.

0:29:46 And are there a couple things that you, you'd point to that have been instrumental in kind of helping you, helping you kind of coach or teach or educate kind of the, the, uh, uh, you know, the, the, the broader market on the technology?

0:29:58 Sure. So again, n- n- no shortcut. [laughs] That's probably the number one thing.

0:30:03 Um, you know, I have to give, um, especially with the practitioners and, and coming up with the practitioner strategy, I have to give most of the, um, credit to, um, the inventor of Talpatch, Fabio.

0:30:14 Um, so he has made it his mission to work primarily with, with practitioners. And so he's, you know, 10 years ago, started reaching out to-

0:30:25 Some of the more open-minded chiropractors, therapists, physical therapists, um, and you know, now we have, um, acupuncturists and, and naturopaths.

0:30:34 And it's, you know, still even m- you know, many, many years later, I would say the typical practitioner that we're working with

0:30:42 is more open-minded and more kind of accepting of holistic methods, um, than your, your typical, you know, naturop- allo- allo- allopathic- Mm-hmm... uh, doctor.

0:30:54 So, uh, you know, I'd say looking, you know, looking for those... L- looking for the right partners a- and just kind of keeping in mind who is gonna be the most, most open-minded to what, to what you do.

0:31:06 You know, in our case, for example, you know, acupuncturists are a really natural,

0:31:12 um, a kind of extension of, of what we do because, uh, A, you know, Tau Patch is used in conjunction with acupuncture, at least it can be. And, um,

0:31:22 it's a really useful tool for an acupuncturist to, to give to their patient after they leave. Because again, normally you lay on an acupuncturist table for an hour, and then you, then you leave,

0:31:35 and it kind of, your body goes back to... I- it's kind of like you're screaming at your body with this therapy, right? And it's, it's intense, and then it goes to nothing. Mm-hmm. And with, with us, it's...

0:31:46 well, it's a lot... first of all, it's a lot more consistent, but also it's more subtle. And because it's subtle and consistent, that's usually, that usually wins. And so

0:31:57 f- you know, finding those right partners who are, um, you know, who would seem like a good fit, just looking at their business model, um, that's step one. And step two is just being open and opportunistic.

0:32:09 I mean, a lot of the doctors that we are working with came to us from our customers who heard about us- Mm...

0:32:16 you know, through, through a friend, and then they brought it to the doctor, and the doctor was just really impressed with the results, and so now they, now, now they tell their other patients. Yeah.

0:32:25 So like the, the, the classic sort of bottoms-up strategy, right? Um- Yeah... you know, as, as some people listening may be familiar with, like even how, how Dropbox became so popular, right?

0:32:33 People in li- these large enterprise organizations were, were using this 'cause it was so much easier, right, than, than emailing files or like sending them through, you know, some sort of other service.

0:32:42 And then ultimately they brought it to their IT folks, and it spread, and it's kind of like the same, same sort of, you know, uh, framework kind of applies here it sounds like. Um, um- But, but- Yeah. Oh, sorry.

0:32:53 Go ahead. But you know what's interesting, like this, this is a really, really good point that you just brought up. So everybody, like in the tech world, everybody wants to be Dropbox, right? Yeah.

0:33:01 Everybody's trying to find that, that same strategy, right? Because, I mean, yes, it wo- it works for Dropbox, so that means let's, let's do something else. Uh, let's do something similar.

0:33:11 But not every company has that same benefit, right?

0:33:14 And so it's really helpful to try to find your unique benefits and leverage those because they could be very different and frankly stronger, and it would work, work better for you. Yeah, 100%.

0:33:26 Like finding those early sort of channel signals, if you will. Mm-hmm. Mm-hmm. Um, one I think...

0:33:32 I, I mean, I'm sure you'd probably agree with most of this, but like one is, um, is just being open to like what is, what is truly working, right, early on, and not being so pigeonholed into one particular like model.

0:33:44 Like just being open. And then, yeah, everyone listening is gonna be working their own devices, their own products, et cetera, and it's not...

0:33:49 this, this sort of play isn't gonna, isn't gonna make sense, but there may be angles of it that you could kind of steal- Sure... and, and, and sort of, uh, tweak, uh, where it would, where it would be applicable.

0:33:58 Um, but let's talk a little bit about, about the clinical work, um, that, uh, you guys have done with, with Tau Patch, and I would presume a lot of that's, um, a lot of that's

0:34:08 u- used to, again, help overcome the natural skepticism that comes with these, these kind of, uh, more leading edge or fren- fringe therapies.

0:34:14 But for, for the Medsider audience that is used to like allocating millions and millions of dollars, right, towards a clinical study, you've, you've been able to accomplish quite, quite a bit probably on, on not that type of budget.

0:34:25 So is there... are there things that you've learned kind of running some of these studies? Or how you've go- how you've...

0:34:31 h- are there some may- maybe unique aspects into how you've man- managed these in order to collect clinical data but like not, not spend, uh, not, not burn through a ton of cash at the same time?

0:34:41 It's a, it's a really good question and a very sore subject to be [laughs]-, to be honest. [laughs] You're absolutely right.

0:34:47 We're, we're a very small company, and we, you know, haven't raised outside funding, and so all research and really everything is, uh, is self-funded for us. And so having studies that are...

0:35:01 so not having those multi-thousand person studies has been a, a difficult thing to overcome for us. However, what, what that has, has also taught us is that there is, there's always gonna be somebody who doesn't...

0:35:18 no matter how good the study is, there's always gonna be someone who pokes a hole in it. And, um, so the way we found out that Tau Patch really helps with multiple sclerosis is by accident.

0:35:30 One of the doctors that we were working with put it on one of his patients who happened to have MS, and then that person got up from the wheelchair and started walking in a straight line within, within minutes of putting it on.

0:35:41 And, uh, so then we decided to do a year, year-long study with... it was 28 patients, and this was, you know, a few years back, so we had, you know, mu- much less capital. And, you know, again, it's a year-long study.

0:35:56 It's 28 people. The results are phenomenal, but because it's not that many people, it's not 28,000, it's only 28, and it wasn't placebo controlled, m- many people just kind of throw, throw that study away.

0:36:10 And so w- what... the way we've been sort of, you know, addressing it since then, and yes, we, we have invested, you know, plenty since then, and we have a, a lot more studies and more coming out.

0:36:21 But what I always say is it actually doesn't matter what the studies say. The only study that matters has a sample of one, and that's not... That, that's you.

0:36:33 The only person it matters whether it works or not for is you, and the only way to know is to try it. And so the way we, we've addressed it is by having a money-back guarantee. Uh, we know that it's completely safe.

0:36:46 We are... So we just got FDA approved literally last week. Um, we've, we've been a Class 1 medical device in Europe, which means it's completely safe. It's has the same safety rating as a Band-Aid.

0:36:58 So if it's completely safe, if there's a money-back guarantee, there's no reason not to try it. And so we have got... We have been hurt by lack of those multi-thousand, uh, person studies. And frankly,

0:37:13 we've had a couple of negative reviews by doctors who have not tried it, who don't have any patients who have tried it,

0:37:21 and they just l- they look at some of the studies and then they look at just h- how it works and they d- cannot... Th- they say, "Well, it seems to be, to be true, therefore it must be fake." Mm-hmm.

0:37:33 Just hearing you kind of describe your experience there, at least at a high level, is, um, um... I, I... There's this quote from, um, the New York Jets football coach, Robert Saleh.

0:37:42 I think it was, like, maybe last summer or something like that, where there was, there was some publicity around Aaron Rodgers and just some of the...

0:37:48 You know, people were kind of critiquing what they were doing and, and he, and he had this quote. He was like, you know, "If, um, um, if you don't have any haters, you're not popping."

0:37:56 And, and so, um, uh, that's obviously very, very loose but, like, I, I, I do kind of generally think the same thing applies.

0:38:02 To your point, you could run a really high-powered, you know, pretty, pretty solid, uh, clinical study that's well-designed. You're still gonna have people that are, that are poke holes in it, right?

0:38:13 And so that shouldn't prevent you from maybe moving forth- moving forward with that, uh, that effort. But- Yeah...

0:38:19 if you have, if you have haters, right, or if you have people that critique it, that's just gonna happen all the time, right? And you shouldn't let it stop you from just kind of moving, moving forward.

0:38:28 Um, you know, like, 'cause the, the reality is, like, not everyone can offer a device, right, you know, that, that... With a, with a money-back guarantee, OTC direct, d- direct to consumer. But- Right...

0:38:39 but, um, but you also shouldn't let, you know, the, you know, people that are gonna naturally just critique and be skeptical of ev- everything you're gonna do, don't let that stop you from kind of moving forward and at least doing something, right?

0:38:50 And so, like, one, one good example is, like, early... Even early on in our, in our, um, in our days at, at Joovv, right?

0:38:55 We, we, we didn't raise outside, outside capital either, and so a lot of the, a lot of the, the margins we reinvested in the, in the business. But wanted to do...

0:39:02 Wanted to produce some clinical data, right, to help substantiate the therapy beyond what was already in the, in the public domain. And so we just tapped into our email list, right?

0:39:09 'Cause we had this really, like, fast-growing email list of people that basically wanted to buy a device, they couldn't afford it from... You know, in most cases couldn't afford it.

0:39:17 And so we, we basically offered the, the device free of, free of charge to use, right? Um, um, and so they could use it for, whatever, eight to 12 weeks as a part of the study.

0:39:26 Uh, and then, um, in exchange a- for, for their, you know, their participation and engagement in, in the study, they, they get... You know, were able to...

0:39:34 They purchased that device at a extreme discount, right, after, after it was over. Right.

0:39:38 And then we partnered with practitioners that had already reached out to us, right, that had a little bit of familiarity with, with, with running studies, that were just naturally interested.

0:39:48 And so they weren't expecting, you know, huge, huge sums of money to help, help with that study. They just had a natural interest in, interest in this, and so we, we made sure that they were...

0:39:56 That we kind of met, met their needs as part of it. So, like, there's creative ways of going about a lot of this stuff. And yeah, were they the most well-designed, high-powered studies?

0:40:03 No, by any stretch of the imagination. But it was something, right?

0:40:06 It w- it, it was something and there's na- You know, any, any, any sophisticated, you know, clinical trialist would probably poke a lot of holes in it but, you know, from our perspective be- better than nothing.

0:40:16 You know what I mean? So, um- Yeah. And, and, and again, you know, it's, it's, it's a tough situation to be in for a startup- Mm-hmm... considering most of... Like, the, the whole study game- Mm...

0:40:26 is designed by very large, really well-funded companies, right? Mm-hmm.

0:40:31 And, um, so this is some also some of my frustration in, in, for example, dealing with some of the, like, nonprofit organizations, particularly around MS or Parkinson's. Um, they are... I don't wanna say...

0:40:44 You know, I don't wanna say anything bad about anyone, but they're really funded primarily by those large companies. And so they... There's kind of...

0:40:53 They're trying to perpetuate this, the, the, the necessity of, of a large study and what a large study is. And again, I, I would urge everyone to start... And in fact, well, uh, uh, it doesn't...

0:41:06 It's not me urging, it's already happening. Mm. Um, especially since COVID happened, a lot more people are taking kind of their personal health into their own hands and they're relying...

0:41:17 I, I think they're relying less than before on those large studies, studies. Again, as long as something is safe and you can try it and see if it's working for you.

0:41:25 Because even if it, uh, even if a study is 30,000 people but it's working for them, but it's still couldn't work, could not work for you possibly, right? Yep, yep. All, all really good points.

0:41:37 Um, I wanna leave enough time for the kind of the rapid-fire portion of this interview but kinda segueing into this idea of funding, right?

0:41:42 'Cause you mentioned, um, you know, uh, Tau Patch hasn't raised external capital. You do have a f- I, I think maybe...

0:41:49 I could be wrong about this, but I think you, you personally, you know, do a fair amount of investing yourself. Um, you're familiar with kinda traditional VC. What, what's been your... What's been...

0:41:57 I guess, you know, when you think about raising capital for Tau Patch, uh, in the traditional sense versus even from, from, you know, private individuals, what's been your kind of, uh, your, your experience with kind of the, the, the latter versus, you know, the, the former?

0:42:10 Sure. Well, so... Sorry, with the latter be- being the- Private-... more crowdfunding... private individual. Yeah, yeah. Yeah, yeah. Crowdfunding, private individuals. Yeah, yep. Um, well, sure.

0:42:19 So, uh, so I, I came into the Tau Patch world a few years ago, um, right around, right before COVID.

0:42:27 And so, uh, we decided to bring Tau Patch from Italy, which is where- Where it was invented and where, you know, most of the practitioner network, uh, had been, um, into th- US, North America, and kind of the rest of the English-speaking world.

0:42:42 And so we were, you know, thinking of what, what's the best, best way of doing that. Um, you know, w-

0:42:49 do we wanna start with a practitioner network, like, like we did in Italy, for example, or do we wanna do something else? And right around that time, COVID hit, and so

0:42:58 doctors couldn't really see patients, and so we were, you know, d- dealing with, um, uh, with some kind of a, a constraint, uh, you know, is a, is a really good idea sometimes, very good.

0:43:09 [laughs] Makes, makes you creative. [laughs] And so we decided to, uh, launch it as a, um, on Indiegogo, which is like a, you know, a Kickstarter- Mm-hmm... an Kickstarter competitor.

0:43:21 And so we just, uh, we did kind of a pr- essentially a pre-sale. And, um, you know, there's pros and cons to everything, but in general, I would say if you can avoid giving away equity in the beginning to an...

0:43:36 Okay, there's, again, there's pros and cons. There's the right or wrong ways to do it, and I realize I'm talking to an investor, so [laughs] Be very careful.

0:43:45 But, uh, I think in your case, you add a lot of strategic value to everybody, you know, you invest in.

0:43:49 And this is like, I would absolutely, you know, highly recommend, uh, working with you simply because it- it's not just money. It's you, you offer so much more.

0:43:59 Um, and I think this is what, that's so much more important than money because money, you know, you can, there- there's plenty of money to go or to go around. Yeah.

0:44:07 Um, and one of the ways of doing this is through, you know, through crowdfunding, um, which is just another way of saying

0:44:15 it's kind of a, it's a sale, but you just have a little bit more time to deliver the product, right? Yep. Yep.

0:44:22 Yeah, and, and, and this, this, I think this idea of crowdfunding with more consumer audiences, it, it definitely applies, I think, to even traditional med tech because

0:44:31 oftentimes we, we, uh, you know, gravitate towards just raising money from, from, um, from your, you know, traditional VCs at, at various stages, right?

0:44:39 Uh, maybe in the, in the la- latter stages being, you know, more, more, uh, private equity folks.

0:44:43 But oftentimes you can get, uh, a project off the ground with a fair amount of capital just raising from your community, right? Um- Yeah... you know, and community could be a bit different.

0:44:52 It could be people that are into health and wellness through a Indiegogo or Kickstarter campaign, right?

0:44:57 Community in maybe traditional med tech is from your physicians, you know, your cardiologists, your vascular surgeons, your OBs, whatever- Yeah...

0:45:03 that want to privately invest, right, in a technology that they, they really know well, um, and they think, you know, has a lot of legs.

0:45:09 And so, um, so I think that that's an important kind of really point, I think, to, to, to, to really, really emphasize is that crowdfunding can look a little bit differently.

0:45:17 But at the end of the day, you're basically raising money in some sort of fashion, right, from, from people who are, uh, you know, typically intimately involved.

0:45:25 They're like, in, in essence, raising their hand in a virtual sense of, like, expressing interest in kind of what you're building. So, um, you know, uh, my, my message is go, go far and wide, right?

0:45:34 If you're in, in the, in the, in, in the throes of raising capital, don't be afraid to do it in a, in a little bit of an unusual kind of way.

0:45:41 So with that said, let's get to the rapid fire portion of the interview, uh, Dmitry. Questions are rapid fire in nature, uh, but feel free to expand a little bit on your answers.

0:45:46 But again, before we get there, taopatch.co. Mentioned it a few times already. T-A-O P-A-T-C-H. Taopatch.co is the website. You can definitely check it out. Learn a little bit more about the, uh, the technology.

0:45:58 In fact, if you're interested, uh, definitely encourage you to go ahead and, and, and pick one up, uh, or pick a few up.

0:46:03 Um, and then of course, we'll link to it in the full write-up on MedSider that will accompany this, uh, this particular podcast.

0:46:08 We'll also link to Dmitry's, uh, LinkedIn profile as well and his, his social, uh, his social channels.

0:46:12 So first question on the docket is, when you think about the next 12 months ahead for Tau Patch, what, uh, what, what's the, the, the, the number one thing you're most excited about?

0:46:21 We're launching a couple of new products, uh, which we will announce within about a month, so I don't want to mention it just yet. [laughs] But, but it's super exciting, uh, number one. Number two,

0:46:31 moving into this, um, the everyone else category. So not, not athletes or people- Mm-hmm...

0:46:37 with neurological disorders, but, um, people interested in longevity, oral wellbeing, um, emotional wellbeing, and mental health.

0:46:45 Um, we- we're seeing a lot of results on the front, and so this is, this is the next area for us. Yeah. That's cool. Good, good, good times. Always fun, always fun when you're actually in market commercializing.

0:46:54 Um, all right. Mm-hmm.

0:46:55 Since starting Tau Patch USA, uh, and, you know, commercializing, uh, the technology to kind of the, the broader kind of English-speaking world, uh, what's the most surprising thing that you've learned? Um, how

0:47:08 some people are not open to new things when they seem too good to be true, and, uh, h- h- how skeptical some people are, which I guess shouldn't be a surprise, but I'm easily excited...

0:47:21 well, skeptical, but also- Mm-hmm... easily excited myself, but, uh, some people are really not. [laughs] Yeah. Really not.

0:47:29 [laughs] Maybe the most surprising thing is how, how kind of, uh, I, I guess ingrained certain people are, right- Yeah...

0:47:34 in their, in their approach, and, and just simply unwilling to kind of think a little bit differently or to even be open to certain things. Um, no idea. Or even, or even open to data, right? Yeah. Yep, yep, for sure.

0:47:45 That, understanding that behavioral psychology of kind of your, your audience, though, is so crucial, and it can be really, really surprising.

0:47:51 Um, but, uh, um, yeah, third question is, you know, if you had a room full of health tech entrepreneurs, right, maybe you got done presenting on, on, on your story, kind of moving from, you know, more traditional tech into, into health tech, uh, and you wanted to leave them with, like, one single thing that's gonna best position them for success, what would it be?

0:48:10 So, uh, it would be the same thing I would give to, uh, not any entrepreneur, not just a health tech entrepreneur. Mm-hmm.

0:48:16 But make sure it's, you're working on something that you're really excited about and really passionate about. And it's, it's textbook advice at this point- Mm-hmm...

0:48:24 but [laughs] just, just to me, it, it's really, really, really probably the, the most impactful thing because if it's... it kind of has to be your life, right, and not just-... work. Mm-hmm.

0:48:35 Um, and if it's not something that you're just- you could see yourself doing for a long time, um, it's gonna be difficult.

0:48:41 And then I'd say the second, uh, and, uh, parallel to that, finding a general direction that's really exciting, right? So- Mm.

0:48:50 And, and the, the specific path might change, but, like, finding the problem, the big problem you're, you're looking at solving or the space that you wanna be in, because, you know, the compounding effects of knowledge and connections and everything else.

0:49:02 Yeah. Yeah, so.

0:49:03 That's, that's a really good point, 'cause, I mean, it's easy to get stuck on, like, maybe one, one niche that you're, like, really passionate about, but maybe that, maybe that's there's not anything really to work on there, right?

0:49:12 Or maybe you haven't hit traction or wh- whatever it may be, right? But, uh, if you're working kind of within the, that broader trend, as you mentioned, right? Yeah. That's important to consider. Like, am I...

0:49:19 Do I get excited about this broader, this broader, uh, this broader trend? Um, it's good stuff. All right.

0:49:24 Last question on the, on the, uh, on the list here is, you know, starting over maybe in your, in your mid-20s or that kind of general timeframe, is there one thing that you'd whisper in the young Dmitry's ear, uh, either from a professional or a personal standpoint?

0:49:37 Honestly, [laughs] I have two answers to this question. First one, buy Bitcoin. [laughs] That's right. [laughs] Second, um, you know, I,

0:49:47 uh, I, I've thought about this que- this question before as well, and honestly, I would say I, I don't think I would do anything that differently.

0:49:54 Yes, there w- there could have been some shortcuts, but pretty, you know, generally very, very happy and don't want... have the philosophy of just not having regrets.

0:50:05 A- and I think that also means, um, accepting the path that, that you've, that I've been on as a correct one. Yeah. All right. Good stuff. Good way to wrap this, wrap- Mm-hmm... this conversation up.

0:50:15 Again, everyone listening, taopatch.co is the website. T-A-O Patch, just as it sounds, taopatch.co.

0:50:22 We'll link to it in the full write-up on MedSider, uh, as well as Dmitry's, uh, LinkedIn profile and his social channels.

0:50:29 Um, in addition, if you're new to MedSider, it's maybe the first, you know, one or two interviews that you've caught, uh, we do publish these write-ups, right, these longer form articles that accompany the podcast episode on the website.

0:50:39 Um, it's kind of an opportunity to go, go back and kind of almost, almost relearn.

0:50:43 Um, um, or if you simply like reading versus listening, uh, it's a good opportunity to kind of, uh, pick up on, on, on insights, uh, a lot of the insights and, and lessons learned that, that Dmitry, uh, shared since, um, uh, since starting, uh, his work with Tao Patch USA.

0:50:58 So, uh, Dmitry, can't thank you enough for, for coming on the program. This is a, a fun health tech-centric, uh, kind of conversation. [laughs] Yeah. Thank you so much. Really great conversation. Yeah.

0:51:06 I'll have you hold on the line real quick. But, uh, for everyone listening, thanks as always for your attention, and until the next episode of MedSider goes live- [upbeat music] Uh, take care. Hey, it's Scott again.

0:51:14 One quick thing before you go. You see, I love bringing you insightful conversations with the best founders and CEOs of medical device and health technology startups.

0:51:21 But here's the thing, I'd be super grateful if you could help me reach even more ambitious doers who share our passion.

0:51:26 So if you found value in this podcast, if you found yourself nodding your head while listening, or if you simply enjoy what we're doing with MedSider, please take a moment to leave us a review. It's super easy.

0:51:35 Just open your Apple Podcasts app or the podcasts app of your choice, search for our show, and scroll down to the ratings and review section.

0:51:41 Leave your honest thoughts and hit that five-star rating if you think we're worthy.

0:51:44 Your feedback is incredibly important, and it's the best way to ensure we keep bringing you awesome discussions with leading founders and CEOs. So take a moment to be a good friend and leave that review today.

0:51:53 As always, thanks for being a part of our journey and for helping MedSider continue to grow and evolve. Your support is greatly appreciated. All right, enough talk about reviews.

0:52:00 Stay tuned for another informative episode coming at you soon. [upbeat music]